Furthermore, in a syngeneic mouse breast cancer model using subcutaneously inoculated 4T1 cells, silencing Prps2 dramatically reduced lung metastasis (S2D and S2E Fig), whereas the growth of the primary tumor was not significantly affected (S2F Fig). Here, PRPS2 is linked to breast carcinoma.